欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0841/003
药品名称
Quatriga extra Nitrogen
活性成分
alanine 9.2 g
arginine 7.9 g
calcium chloride 0.28 g
fish oil, rich in omega 3-acids 4.3 g
glucose monohydrate 85.0 g
glycine 7.2 g
histidine 1.5 g
isoleucine 3.3 g
leucine 4.8 g
lysine 4.3 g
magnesium sulfate 0.61 g
medium-chain triglycerides 8.7 g
methionine 2.8 g
olive oil monohydrate 7.2 g
phenylalanine 3.3 g
potassium chloride 2.3 g
proline 7.3 g
serine 4.3 g
sodium glycerophosphate 2.3 g
sodium acetate 1.6 g
soybean oil monohydrate 8.7 g
taurine 0.65 g
threonine 2.9 g
tryptophan 1.3 g
tyrosine 0.26 g
valine 4.1 g
zinc sulfate 0.0 g
剂型
Emulsion for infusion
上市许可持有人
Fresenius Kabi AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Italy (IT)
许可日期
2018/09/18
最近更新日期
2024/02/21
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PAR
|
SE/H/0841/003_PAR
Date of last change:2018/12/19
Final PL
|
SE/H/0841/003_Final PL
Date of last change:2018/10/17
Final SPC
|
SE/H/0841/003_Final SPC
Date of last change:2018/10/17
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase